Breaking News - The Fly

Open Search

EMBC

Embecta

$

()

Embecta raises FY24 adjusted EPS view to $1.95-$2.15 from $1.90-$2.10

EMBC

2/9/2024 - 06:33am

Embecta reports Q1 adjusted EPS 61c, consensus 45c

EMBC

2/9/2024 - 06:31am

Embecta announces FDA 510(k) submission for insulin patch pump

EMBC

1/9/2024 - 06:02am

Embecta: FDA safety notice has no impact on any embecta syringe products

EMBC

12/1/2023 - 06:01am

Embecta reports Q4 adjusted EPS 59c, consensus 40c

EMBC

11/21/2023 - 05:36am

Embecta initiated with a Peer Perform at Wolfe Research

EMBC

10/20/2023 - 04:50am

Embecta price target lowered to $17 from $25 at BofA

EMBC

10/18/2023 - 07:25am

Embecta raises FY23 adjusted EPS view to $2.75-$2.80 from $2.50-$2.60

EMBC

8/8/2023 - 11:04am

Embecta reports Q3 adjusted EPS 69c, consensus 46c

EMBC

8/8/2023 - 11:01am

Embecta assumed with an Underweight at Morgan Stanley

EMBC

5/30/2023 - 07:01am

Embecta raises FY23 adjusted EPS view to $2.50-$2.60 from $2.20-$2.35

EMBC

5/12/2023 - 06:34am

Embecta reports Q1 adjusted EPS 75c, consensus 49c

EMBC

5/12/2023 - 06:31am

Embecta, Tidepool partner to develop automated insulin delivery system

EMBC

5/12/2023 - 06:16am